Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DFE Pharma

DFE Pharma
2006 FOUNDED
PRIVATE STATUS
Buyout/LBO LATEST DEAL TYPE (Announced)
2 FINANCING ROUNDS
Description

Developer, producer and supplier of excipients in Germany. The company's offerings include filler/binders, super disintegrants for oral solid dose and carriers for inhalation, created by working closely with pharmaceutical companies around the world, collaborating in original research, supporting their go to market strategies and fine-tuning our products to ensure that their medicines deliver exactly the right outcomes for patients.

Ownership Status
Privately Held (backing)
Financing Status
Pending Transaction (PE)
Primary Industry
Pharmaceuticals
Primary Office
  • P.O. Box 20 21 20
  • 47574 Goch
  • Germany

+49 02823 0000000

DFE Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DFE Pharma‘s full profile, request access.

Request full access to PitchBook

DFE Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore DFE Pharma‘s full profile, request access.

Request full access to PitchBook

DFE Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Bas van Driel Chief Executive Officer
Mark Spiers Chief Financial Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »